The SynerFuse Team

The SynerFuse team is experienced in growing startups and building value for shareholders. The team is composed of experts in clinical neuroscience, product development, intellectual property, FDA regulation and reimbursement, along with a high degree of expertise in spinal surgery and neuromodulation.


Management Team


Justin Zenanko, CPA, MACS
Co-Founder, Chief Executive Officer and Director
Mr. Zenanko is a Certified Public Accountant with extensive experience in corporate finance and startup development. He serves as the Senior Vice President of Corporate Development and before that served as the first CFO of Recombinetics, Inc., where he led fundraising efforts resulting in $34 million in angel funding and an additional $34 million in Series A funding in August 2018 from a strategic investor. Mr. Zenanko started devoting all of his time as our CEO beginning October 15, 2018; in addition to this, he also serves on the Board of Directors at Recombinetics, Inc.

He also holds a Bachelor of Arts degree with majors in Accounting, Economics with Emphasis in Finance, and Marketing from Simpson College. Mr. Zenanko holds a Master of Arts in Christian Studies from Crown College.


Gregory F. Molnar, PhD
Co-Founder, Chief Scientific Officer and Director
Dr. Molnar has over 20 years of experience as a medical device innovator. He currently serves as an Associate Professor in the Department of Neurology at the University of Minnesota (UMN) and provides leadership to the clinical and preclinical research teams across the UMN Deep Brain Stimulation (DBS) Research program.

Dr. Molnar began his career at Medtronic. He served as the Director of Neuromodulation Research and led his team of scientists to advance our understanding of several therapies including DBS, Spinal Cord Stimulation, Sacral Nerve Stimulation, Gastric Stimulation and Intrathecal Drug Infusion. Dr. Molnar has authored numerous patents and publications in the neuromodulation space, and his research and inventions benefit patients today. 


Susan Alpert, PhD, MD  
Chief Medical Officer and Chief Regulatory Officer.
Dr. Alpert, the Principal of SFA Regulatory, LLC, is a health care industry executive with a unique background of regulatory, clinical, business and technology experience, including a history of working at the interface of government and industry within early-stage, small startups and large-scale mature initiatives. She currently serves as an advisor to a variety of organizations involved with technology, regulatory compliance and business innovation aimed at improving health care quality, cost-effectiveness and safety.

Prior to her current role, she served as Senior Vice President, Global Regulatory Affairs at Medtronic Inc., and prior to joining the medical device industry, she served as Director of the Office of Device Evaluation at the FDA Center for Devices and Radiological Health. She has served on the boards of numerous professional organizations including the National Space Biomedical Research Institute, Regulatory Affairs Professional Society, Women Business Leaders, Medical Technology Leadership Forum and the Food and Drug Law Institute.


Beth A. Lindborg, MS, MBA
Vice President of Operations
Ms. Lindborg has a technical/business hybrid background that facilitates effective communication across all levels of medically based organizations. She has a focus in product management, competitive and market intelligence, strategic partnerships, and “voice of the customer” research in the life science and medical device industries.

Ms. Lindborg previously served as Director of Research and Marketing at BRTI Life Sciences. She holds an MS, in Molecular, Cellular, Developmental Biology and Genetics from the University of Minnesota and an MBA with a Medical Industry focus from the Carlson School of Management at the University of Minnesota.